Vietnam Nebulizer Market, By Type (Jet, Mesh, Ultrasonic), By Application (COPD, Cystic Fibrosis, Asthma, Others), By End User (Hospitals And Clinics, Emergency Centers, Home Healthcare), By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 6.71 Million
CAGR (2026-2031)	7.85%
Fastest Growing Segment	Jet
Largest Market	Southern Vietnam
Market Size (2031)	USD 10.56 Million

Market Overview

The Vietnam Nebulizer Market will grow from USD 6.71 Million in 2025 to USD 10.56 Million by 2031 at a 7.85% CAGR. A nebulizer is a medical device designed to atomize liquid medication into a fine mist for direct inhalation into the lungs, primarily utilized in managing various respiratory conditions. The Vietnam Nebulizer Market is largely propelled by the increasing prevalence of chronic respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease, alongside rising environmental pollution and a steadily growing geriatric population. Furthermore, ongoing improvements in healthcare infrastructure and enhanced public awareness regarding efficient respiratory therapy significantly support market growth.

According to information from the Ministry of Health, from the beginning of 2025 to November 2025, Vietnam registered over 132,000 cases of seasonal flu, highlighting the considerable burden of respiratory illnesses within the country. A notable challenge that could hinder market expansion, however, is the elevated cost associated with advanced nebulizer technologies and the limited scope of reimbursement policies, potentially constraining accessibility for a wider patient demographic.

Key Market Drivers

Rising Respiratory Disease Prevalence Drives Nebulizer Demand
Rising prevalence of respiratory diseases significantly drives the Vietnam Nebulizer Market. The increasing incidence of chronic conditions such as asthma and Chronic Obstructive Pulmonary Disease necessitates effective respiratory management tools. According to Qualtech, in January 2026, a high prevalence rate of 4.2% for Chronic Obstructive Pulmonary Disease (COPD) was observed among the Vietnamese population over 40 years old, alongside 4.1% of citizens struggling with asthma. This substantial patient pool directly translates into a heightened demand for nebulizer devices for medication delivery, particularly for those requiring frequent or long-term therapy. The consistent burden of such illnesses underscores the essential role nebulizers play in improving patient quality of life and managing acute exacerbations.

Air Pollution Increases Nebulizer Demand and Signals Import Dependence
Compounding this challenge are the high levels of air pollution across Vietnam, which exacerbate existing respiratory conditions and contribute to new diagnoses. Fine particulate matter irritates the respiratory system, triggering symptoms and increasing the need for therapeutic interventions like nebulization. According to IQAir, on May 29, 2026, Hanoi's average PM2.5 concentration in 2025 was 45.9 µg/m³, which was 9.1 times the World Health Organization annual guideline. This environmental factor intensifies the urgency for accessible and efficient nebulizer solutions. Furthermore, the broader medical device market in Vietnam is seeing considerable activity; according to SGGP English Edition, in June 2026, the Republic of Korea held the largest share of Vietnam's medical device import market, accounting for 16.3% of total imports. This highlights the reliance on imported medical technology to meet evolving healthcare demands.

Download Free Sample Report

Key Market Challenges

Cost and Reimbursement Barriers Impede Market Growth
The elevated cost of advanced nebulizer technologies combined with limited reimbursement policies presents a significant impediment to the growth of the Vietnam Nebulizer Market. The high price points for sophisticated devices often place them beyond the financial reach of a substantial segment of the patient demographic, particularly those in lower-income brackets or rural areas, directly constraining purchase volumes. This financial barrier limits the adoption of more effective, newer generation nebulizers, leading to a slower market penetration of these products.

Limited Reimbursement and Higher Out-of-Pocket Costs Suppress Demand
Furthermore, the restricted scope of reimbursement from national health insurance or private providers for nebulizer purchases, especially for the more advanced or specialized models, compels patients to bear a larger out-of-pocket expense. This reduces the overall affordability and accessibility of essential respiratory therapy, despite the increasing prevalence of chronic respiratory diseases. According to the Vietnam Social Security (VSS), in 2025, the average out-of-pocket health expenditure per insured person for medical devices not fully covered by social insurance schemes represented a notable percentage of disposable income, thereby reducing the likelihood of investment in higher-cost therapeutic equipment. This financial burden directly curtails market expansion by suppressing demand among a wider patient population that could otherwise benefit from nebulizer therapy.

Key Market Trends

Expansion of Home Healthcare Drives Nebulizer Demand
The expansion of home healthcare settings is a significant trend in the Vietnam Nebulizer Market, shifting patient care to domestic environments. Driven by an aging population and preference for in-home medical services, this trend directly increases demand for portable, user-friendly nebulizers. Patients managing chronic respiratory conditions at home require personal devices for consistent medication delivery, reducing hospital reliance and empowering individuals. According to a joint report by the Vietnam Chamber of Commerce and Industry (VCCI) and UNFPA, as cited by Vietnam News in April 2026, Vietnam is projected to have approximately 20 million potential customers for elderly care services by 2035, indicating a substantial need for home-based medical solutions.

Government Initiatives Expand Access and Affordability
Supportive government healthcare initiatives are concurrently influencing the Vietnam Nebulizer Market by enhancing accessibility and affordability. These initiatives involve strategic public health investments and policy adjustments, broadening coverage and improving medical device procurement. Such governmental focus helps overcome cost barriers and extends essential respiratory therapies to a wider population, fostering an environment conducive to market growth. According to Vietnam News in November 2025, the government proposed an investment exceeding VND125.4 trillion (approximately US$4.75 billion) for a national target program on healthcare, population, and development spanning 2026 to 2035, which is expected to bolster the healthcare ecosystem and facilitate greater nebulizer market penetration.

Segmental Insights

Drivers of Jet Nebulizer Growth in Vietnam
The Jet segment is experiencing rapid growth in the Vietnam Nebulizer Market due to its established efficacy and cost-effectiveness within a price-sensitive healthcare landscape. Jet nebulizers offer broad compatibility with diverse medications, including bronchodilators and corticosteroids, enabling tailored treatment for various respiratory conditions affecting both upper and lower airways. Their widespread acceptance and familiarity among healthcare providers, coupled with proven reliability for continuous use in both public and private institutions across Vietnam, significantly drive adoption. Furthermore, the escalating prevalence of respiratory ailments, exacerbated by urbanization and environmental factors in major cities, along with expanding healthcare infrastructure and initiatives like the Ministry of Health's Healthy Lung Program, further fuels the demand for these essential devices.

Regional Insights

Southern Vietnam Emerges as Nebulizer Market Leader Driven by Ho Chi Minh City's Economic Strength and Advanced Healthcare Infrastructure
Southern Vietnam notably dominates the Vietnam Nebulizer Market, primarily driven by its status as the nation's economic and financial hub, particularly Ho Chi Minh City. This robust economic prosperity results in higher disposable incomes, enabling increased consumer investment in essential healthcare products such as nebulizers. The region also boasts a highly developed healthcare infrastructure, comprising numerous advanced hospitals, clinics, and specialized care centers that readily adopt modern medical technologies for respiratory care. Additionally, the flourishing private healthcare sector actively expands access to advanced nebulizer treatments. The significant prevalence of respiratory ailments further fuels demand for these devices across the region.

Recent Developments

• In September 2025, Omron Healthcare Manufacturing Vietnam enhanced its production capabilities within Vietnam. The expansion specifically targeted increasing the manufacturing capacity for nebulizer devices. This move was intended to address the growing demand across the Asia-Pacific region and to improve overall supply chain efficiency. Following this expansion, Omron reported a 14% year-on-year growth in Vietnam-based revenues for its respiratory device portfolio, with operating margins improving to approximately 18.3%, indicating a strengthened position in the Vietnam Nebulizer Market.
• In August 2025, Long Châu, a prominent pharmacy chain in Vietnam, and OMRON Healthcare announced an expanded strategic collaboration focusing on the Vietnamese market. This partnership aimed to broaden the range of at-home health monitoring and care devices available. As part of this initiative, Long Châu began distributing OMRON nebulizers throughout Vietnam, integrating them into its portfolio of home-care medical equipment. These nebulizers were specifically intended to support respiratory care for common conditions like asthma and bronchitis, demonstrating particular utility for pediatric and elderly patients in the Vietnam Nebulizer Market.
• In July 2025, PARI GmbH, a company specializing in respiratory care, established a strategic partnership with a leading telehealth provider. This collaboration was formed to deliver integrated nebulization solutions within the Vietnamese healthcare landscape. The initiative reflected an evolving trend towards telemedicine, where combining nebulization therapy with remote patient monitoring capabilities holds the potential to significantly improve treatment outcomes. This strategic alliance underscored Vietnam's emergence as a dynamic market for advanced respiratory devices and digital health infrastructure.
• In July 2024, CHIDO, a company active in the medical device sector, introduced an updated version of its handheld nebulizer, model CNB69026, within the Vietnam Nebulizer Market. This new product was strategically designed to serve both home healthcare needs and medical unit applications across the country. The launch aimed to enhance accessibility to modern respiratory therapy, providing Vietnamese consumers and healthcare providers with an efficient device for managing various respiratory conditions. This release marked a notable development in portable nebulization technology available in Vietnam, catering to increasing demand for convenient and effective treatment solutions.

Key Market Players

• Omron
• Philips
• Drive DeVilbiss
• Medline
• Omron Healthcare
• Local Distributors
• GE Healthcare
• Siemens Healthineers
• Breas Medical
• Fisher & Paykel

By Type	By Application	By End User	By Region
Jet Mesh Ultrasonic	COPD Cystic Fibrosis Asthma Others	Hospitals And Clinics Emergency Centers Home Healthcare	Northern Central Southern

Report Scope:

In this report, the Vietnam Nebulizer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vietnam Nebulizer Market, By Type:

• Jet
• Mesh
• Ultrasonic

• Vietnam Nebulizer Market, By Application:

• COPD
• Cystic Fibrosis
• Asthma
• Others

• Vietnam Nebulizer Market, By End User:

• Hospitals And Clinics
• Emergency Centers
• Home Healthcare

• Vietnam Nebulizer Market, By Region:

• Northern
• Central
• Southern